Abstract
We describe a patient with severe combined immunodeficiency because of aberrations in adenosine deaminase (ADA) who despite adequate replacement with polyethylene glycol-linked ADA (PEG-ADA) for 13 years developed Burkitt's lymphoma. Although treatment corrected the metabolic abnormalities caused by ADA deficiency, it failed to fully restore cellular immunity.
Original language | English |
---|---|
Pages (from-to) | 93-95 |
Number of pages | 3 |
Journal | Journal of Pediatrics |
Volume | 151 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jul 2007 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health